<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VRPX
Virpax Pharmaceuticals
$
()


  • Virpax Pharmaceuticals files to sell common stock and warrants, no amount given

    4/18/2024 - 16:23pm
  • Scilex enters release, settlement agreement with Virpax Pharmaceuticals

    3/15/2024 - 09:05am
  • Virpax Pharmaceuticals Inc trading halted, news pending

    2/29/2024 - 19:50pm
  • Virpax announces settlement of litigation with Sorrento and Scilex

    2/27/2024 - 07:51am
  • Virpax Pharmaceuticals announces 1-for-10 reverse stock split

    2/27/2024 - 07:39am
  • Virpax announces preliminary results of Probudur study with U.S. Army

    2/7/2024 - 07:36am
  • Virpax Pharmaceuticals receives noncompliance notification from Nasdaq

    11/17/2023 - 07:13am
  • Virpax Pharmaceuticals CEO Anthony Mack resigns

    11/17/2023 - 07:12am
  • Virpax says CRADA with USAISR to evaluate Probudur extended to September 2024

    10/12/2023 - 08:19am
  • Virpax Pharmaceuticals announces results of Probudur dose escalation studies

    9/27/2023 - 09:05am
  • Virpax Pharmaceuticals provides update on Scilex lawsuit

    9/5/2023 - 09:10am
  • Virpax files provisional patent application for intranasal delivery

    7/13/2023 - 09:07am
  • Virpax Pharmaceuticals CFO Chipman to resign, Shah named next CFO

    6/20/2023 - 16:12pm
dynamic_feed Breaking News